Kegg medicus dgroup
| DG02932 | |
| DG番号 | DG02932 |
| 分類 | DGroup |
| 名称 | SLCO1B3 substrate TYPE Metabolism |
| ステム | - |
| 構造式 |  |
| メンバー | D02554 Rifaximin (JAN/USAN/INN) D00400 Valsartan (JP18/USP/INN) DG00355 Atorvastatin D07474 Atorvastatin (INN) D00887 Atorvastatin calcium anhydorous D02258 Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP18) D11095 Atorvastatin calcium propylene glycol solvate D11472 Remdesivir (JAN/USAN) D10582 Dasabuvir, ombitasvir, paritaprevir and ritonavir D10745 Ombitasvir, paritaprevir and ritonavir D11014 Glecaprevir and pibrentasvir D10801 Letermovir (JAN/USAN/INN) DG01169 Sulfobromophthalein D08548 Sulphobromophthalein (BAN) D02210 Sulfobromophthalein sodium (JP18) D09799 Carotegrast methyl (JAN) D09987 Vaniprevir (JAN/USAN/INN) D10711 Pemafibrate (JAN) |
| 上位グループ | Transporter substrate |
| 注釈1 | - |
| 注釈2 | - |